Volume 1; Issue 2

Clinical Lymphoma

Volume 1; Issue 2
1

Randomized Study of IDEC-Y2B8 (Zevalin™) Compared to Rituximab for B-Cell NHL

Year:
2000
Language:
english
File:
PDF, 96 KB
english, 2000
3

The Expanding Frontier of Radioimmunotherapy of Relapsed Non-Hodgkin's Lymphoma

Year:
2000
Language:
english
File:
PDF, 46 KB
english, 2000
4

Commentary on “DAB389IL-2 (ONTAK): A Novel Fusion Toxin Therapy for Lymphoma”

Year:
2000
Language:
english
File:
PDF, 38 KB
english, 2000
6

Iodine-131 Tositumomab (Bexxar™) Has Activity in Transformed Low-Grade Non-Hodgkin's Lymphoma

Year:
2000
Language:
english
File:
PDF, 91 KB
english, 2000
8

DAB389IL-2 (ONTAK): A Novel Fusion Toxin Therapy for Lymphoma

Year:
2000
Language:
english
File:
PDF, 209 KB
english, 2000
10

The History of the Development of Vaccines for the Treatment of Lymphoma

Year:
2000
Language:
english
File:
PDF, 1.90 MB
english, 2000